Drug Profile


Alternative Names: Arteon Inj; TEI 9090; TTC 909

Latest Information Update: 10 Dec 2001

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Teijin Pharma
  • Developer Taisho Pharmaceutical; Teijin Pharma
  • Class Antiplatelets; Antiulcers; Peripheral vasodilators; Prostaglandins; Small molecules; Vascular disorder therapies
  • Mechanism of Action Platelet aggregation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Arterial occlusive disorders; Intracranial thrombosis; Ischaemic heart disorders

Most Recent Events

  • 10 Dec 2001 Discontinued-Clinical for Ischaemic heart disorders in Japan (Unknown route)
  • 10 Dec 2001 Discontinued-preregistration for Arterial occlusive disorders in Japan (Injection)
  • 10 Dec 2001 Discontinued-preregistration for Cerebral thrombosis in Japan (Injection)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top